Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript Inv. presentation Class action filed
|
ABIOMED INC (ABMD)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/06/2023 |
SC 13G/A
| BAILLIE GIFFORD & CO reports a 0% stake in ABIOMED, INC. |
01/03/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
12/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
12/27/2022 |
4
| SUTTER MARTIN P (Director) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 123,370 shares
@ $0 |
|
12/27/2022 |
4
| PUHY DOROTHY E (Director) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 3,255 shares
@ $0 Disposed/sold 11,335 shares
@ $0 |
|
12/27/2022 |
4
| Trapp Todd A (VICE PRESIDENT, CFO) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 14,166 shares
@ $0 Disposed/sold 7,000 options to buy
@ $266.39, valued at
$1.9M
Disposed/sold 6,530 options to buy
@ $223.9, valued at
$1.5M
Disposed/sold 3,737 options to buy
@ $283.88, valued at
$1.1M
Granted 26,023 rights
@ $0 Disposed/sold 26,023 rights
@ $0 |
|
12/27/2022 |
4
| Plano Matthew T. (VP, GLOBAL OPERATIONS) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 8,406 shares
@ $0 Disposed/sold 922 options to buy
@ $223.9, valued at
$206.4k
Disposed/sold 2,000 options to buy
@ $381.97, valued at
$763.9k
Disposed/sold 5,000 options to buy
@ $266.39, valued at
$1.3M
Disposed/sold 2,765 options to buy
@ $283.88, valued at
$784.9k
Granted 12,490 rights
@ $0 Disposed/sold 12,490 rights
@ $0 |
|
12/27/2022 |
4
| MINOGUE MICHAEL R (CHAIRMAN, PRESIDENT, CEO) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 166,670 shares
@ $0 Disposed/sold 243,962 shares
@ $0 Disposed/sold 85,000 options to buy
@ $21.55, valued at
$1.8M
Disposed/sold 35,000 options to buy
@ $66.25, valued at
$2.3M
Disposed/sold 30,500 options to buy
@ $99.62, valued at
$3M
Disposed/sold 33,000 options to buy
@ $134.51, valued at
$4.4M
Disposed/sold 30,000 options to buy
@ $381.97, valued at
$11.5M
Disposed/sold 50,000 options to buy
@ $266.39, valued at
$13.3M
Disposed/sold 20,898 options to buy
@ $223.9, valued at
$4.7M
Disposed/sold 30,000 options to buy
@ $283.88, valued at
$8.5M
Granted 96,265 rights
@ $0 |
|
12/27/2022 |
4
| Greenfield Andrew J (VP, CHIEF COMMERCIAL OFFICER) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 23,484 shares
@ $0 Disposed/sold 5,000 options to buy
@ $99.62, valued at
$498.1k
Disposed/sold 6,500 options to buy
@ $134.51, valued at
$874.3k
Disposed/sold 4,000 options to buy
@ $381.97, valued at
$1.5M
Disposed/sold 7,000 options to buy
@ $266.39, valued at
$1.9M
Disposed/sold 4,896 options to buy
@ $223.9, valued at
$1.1M
Disposed/sold 2,868 options to buy
@ $283.88, valued at
$814.2k
Granted 27,458 rights
@ $0 Disposed/sold 27,458 rights
@ $0 |
|
12/27/2022 |
4
| Began Marc A (VP & GENERAL COUNSEL) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 12,237 shares
@ $0 Disposed/sold 7,000 options to buy
@ $266.39, valued at
$1.9M
Disposed/sold 5,125 options to buy
@ $223.9, valued at
$1.1M
Disposed/sold 2,961 options to buy
@ $283.88, valued at
$840.6k
Granted 24,029 options to buy
@ $0 Disposed/sold 24,029 options to buy
@ $0 |
|
12/27/2022 |
4
| Johnson Paula A (Director) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 1,659 shares
@ $0 |
|
12/27/2022 |
4
| RIVET JEANNINE M (Director) has filed a Form 4 on ABIOMED INC
Txns:
| Granted 9,285 shares
@ $0 |
|
12/27/2022 |
4
| THOMAS PAUL (Director) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 6,357 shares
@ $0 |
|
12/27/2022 |
4
| Rolle Myron L (Director) has filed a Form 4 on ABIOMED INC
Txns:
| Disposed/sold 1,721 shares
@ $0 |
|
12/27/2022 |
4
| Van Gorder Chris (Director) has filed a Form 4 on ABIOMED INC
Txns:
| Granted 7,410 shares
@ $0 |
|
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
12/22/2022 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Second Amended and Restated Certificate of Incorporation of ABIOMED, Inc",
"Second Amended and Restated By-Laws of ABIOMED, Inc",
"First Amendment, effective as of December 21, 2022, to the Change of Control Severance Agreement, effective as of April 6, 2018, by and between ABIOMED, Inc. and Todd Trapp" |
|
12/22/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|